[go: up one dir, main page]

TW200701983A - Novel use of peptide compounds for treating dyskinesia - Google Patents

Novel use of peptide compounds for treating dyskinesia

Info

Publication number
TW200701983A
TW200701983A TW094123422A TW94123422A TW200701983A TW 200701983 A TW200701983 A TW 200701983A TW 094123422 A TW094123422 A TW 094123422A TW 94123422 A TW94123422 A TW 94123422A TW 200701983 A TW200701983 A TW 200701983A
Authority
TW
Taiwan
Prior art keywords
peptide compounds
novel use
treating dyskinesia
treating
dyskinesia
Prior art date
Application number
TW094123422A
Other languages
Chinese (zh)
Inventor
Thomas Stohr
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04011833A external-priority patent/EP1604654A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of TW200701983A publication Critical patent/TW200701983A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to the use of a class of peptide compounds for treating primary or/and secondary dyskinesias such as tardive dyskinesia.
TW094123422A 2004-05-18 2005-07-11 Novel use of peptide compounds for treating dyskinesia TW200701983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57193204P 2004-05-18 2004-05-18
EP04011833A EP1604654A1 (en) 2004-05-18 2004-05-18 Novel use of peptide compounds for treating dyskinesia

Publications (1)

Publication Number Publication Date
TW200701983A true TW200701983A (en) 2007-01-16

Family

ID=34969829

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094123422A TW200701983A (en) 2004-05-18 2005-07-11 Novel use of peptide compounds for treating dyskinesia

Country Status (4)

Country Link
KR (1) KR20070010168A (en)
IL (1) IL179072A0 (en)
NO (1) NO20065829L (en)
TW (1) TW200701983A (en)

Also Published As

Publication number Publication date
KR20070010168A (en) 2007-01-22
NO20065829L (en) 2007-01-25
IL179072A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
UA86808C2 (en) Novel use of peptide compounds for treating dyskinesia
MX2008002293A (en) Novel use of peptide compounds for treating muscle pain.
TW200640924A (en) VEGF-R2 inhibitors and methods
UA88166C2 (en) Use of peptide compounds for treating essential tremor and other tremor syndromes
TW200701982A (en) Novel use of peptide compounds for treating pain in trigeminal neuralgia
TW200602029A (en) Inhibitors of IAP
ZA200704910B (en) Pyrrolidine inhibitors of IAP
SG161310A1 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
IL161966A0 (en) Aryloxyphenyl and arylsulfanylphenyl
PL1761520T3 (en) Kinase inhibitors
TW200716632A (en) Integrase inhibitor compounds
ZA200701137B (en) Triazolophthalazines
MX2007008137A (en) Triazolophthalazines.
IL163777A0 (en) Kinase inhibitors
CL2007002380A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis.
EA200700702A1 (en) LOKSAPINA ANALOGUES AND METHODS OF THEIR APPLICATION
TW200630367A (en) Substituted adenines and the uses thereof
MX2008007808A (en) Rifamycin analogs and uses thereof.
AU2003290592A1 (en) Antitumor benzoylsulfonamides
UA85505C2 (en) Kinase inhibitors
BRPI0514672A (en) fusobacterium polypeptides and methods of use
TW200701983A (en) Novel use of peptide compounds for treating dyskinesia
MY139442A (en) Novel use of peptide compounds for treating dyskinesia
UA94604C2 (en) Neuroprotective compounds and uses thereof
GB0411180D0 (en) Treatment of ballast water